ATX-295

N/A

Report date: 2025/08/13 14:02:49
NME

Base Information

Drug NameATX-295
Drug Alias NameKIF18A inhibitors (Accent Therapeutics)Kinase-like protein 18A inhibitor (Accent Therapeutics)ATX-295
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionKinesin-like protein KIF18A inhibitors
TargetsKinesin-like protein KIF18A
Therapy Area/IndicationsSolid tumoursOvarian NeoplasmsTriple Negative Breast Neoplasms +[5] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesAccent Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesAccent Therapeutics Inc
Inactive CompaniesN/A
Active IndicationsSolid tumoursOvarian NeoplasmsTriple Negative Breast Neoplasms +[5] 
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A